Ioglucomide: a new nonionic myelographic agent. Preclinical studies.

Ioglucomide, a new iodinated nonionic contrast medium directed primarily toward myelographic use, was subjected to an extensive toxicological examination in animals. In the majority of studies, ioglucomide was compared directly with metrizamide. In some respects, including freedom from production of arachnoiditis, ioglucomide and metrizamide were comparable. However, acute toxicity after intravenous injection or instillation into cerebrospinal fluid was significantly less for ioglucomide. Also, in contrast to metrizamide, ioglucomide produced no evidence of any type of convulsive activity after subarachnoid administration. The improved safety of ioglucomide could not be related to osmolality; therefore, the importance of osmolality for nonionic myelographic agent safety is questioned.
AuthorsR M Hopkins, M D Adams, D H Lau, J M Creighton, G B Hoey
JournalRadiology (Radiology) Vol. 140 Issue 3 Pg. 713-7 (Sep 1981) ISSN: 0033-8419 [Print] UNITED STATES
PMID7280240 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Contrast Media
  • Iodobenzoates
  • Triiodobenzoic Acids
  • ioglucomide
  • Metrizamide
  • Animals
  • Brain (drug effects)
  • Contrast Media
  • Dogs
  • Drug Evaluation, Preclinical
  • Evaluation Studies as Topic
  • Injections, Intravenous
  • Iodobenzoates (administration & dosage, adverse effects)
  • Kinetics
  • Lethal Dose 50
  • Meninges (drug effects)
  • Metrizamide (administration & dosage, adverse effects)
  • Mice
  • Myelography (adverse effects, methods)
  • Rabbits
  • Rats
  • Triiodobenzoic Acids (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: